سعر باليزاج 0.1% جل موضعي 15 جم 2022

Topical gel containing tazarotene 0.1% in a 15 g pack, marketed in Egypt.

• Topical treatment of plaque psoriasis of up to 20% body surface areaPopulation: AdultsDailyMed (NLM)
• Topical treatment of mild to moderate facial acne vulgaris (0.1% gel)DailyMed (NLM)

• Local skin reactions such as pruritus, burning/stinging, erythema, desquamation and irritation; hypersensitivity reactions including urticaria have been reported.International label, same formulation · DailyMed (NLM)

• Contraindicated in pregnancy (retinoid; may cause fetal harm).International label, same formulation · DailyMed (NLM)
• Known hypersensitivity to any of its components.International label, same formulation · DailyMed (NLM)

• Embryofetal toxicity: females of child-bearing potential should have a negative pregnancy test within 2 weeks before starting and use effective contraception during treatment.International label, same formulation · DailyMed (NLM)
• Local irritation (pruritus, burning, erythema, peeling) may occur; do not use on eczematous skin. Avoid sunlight and sunlamps and use sunscreen; caution with photosensitising drugs.International label, same formulation · DailyMed (NLM)

• Contraindicated in pregnancy: tazarotene is teratogenic in animals and the level of exposure required for teratogenicity in humans is unknown.International label, same formulation · DailyMed (NLM)

• Tazarotene: Prodrug converted to tazarotenic acid, which binds retinoic acid receptors (relative selectivity for RAR-beta and RAR-gamma); the exact mechanism in psoriasis and acne is not fully known.